Distributor Licensure

Tough, Rigorous and Consistent Licensure Standards Protect the Health of Patients

The introduction of counterfeit or adulterated medicines into the supply chain is a serious issue that can adversely affect the safety of prescription medicines and the health of patients. HDA supports the federal Drug Supply Chain Security Act’s requirement that supply chain members only do business with Authorized Trading Partners, defined as having a valid state license or FDA registration. Having strong, consistent distributor licensing is critical to ensuring the integrity of the supply chain.



The resources below address the industry’s perspective on ensuring consistent licensure standards.


Our Advocacy Work on Behalf of Members 

HDA reviews key priority issues and advocates on behalf of its pharmaceutical distributor members in areas like standards, public policies and business processes. HDA members have a powerful, unique voice and perspective and an opportunity to help educate lawmakers and inform public policy.

Explore our resources

Not a member? Join today.

Other Issues